Document is current
Any future updates will be listed below
-
Authors
Liatsou, Ioanna https://orcid.org/0000-0003-3423-6401
Fu, Yingli https://orcid.org/0000-0003-1516-1854
Li, Zhi
Hasan, Mahmud https://orcid.org/0000-0003-0192-6166
Guo, Xin
Yu, Jing https://orcid.org/0000-0003-3835-7841
Piccolo, Joseph
Cartee, Allison https://orcid.org/0000-0003-2106-0873
Wang, Hao https://orcid.org/0000-0001-6489-6940
Du, Yong https://orcid.org/0000-0002-0237-6154
Bryan, Jeffrey https://orcid.org/0000-0002-6820-9850
Gabrielson, Kathleen
Kraitchman, Dara L. https://orcid.org/0000-0002-0875-5323
Sgouros, George https://orcid.org/0000-0002-4553-2866
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 CA116477, R01 CA187037, R01 CA239124)
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 14 November 2023
First Online: 18 December 2023
Declarations
:
: Animal protocols were approved by the Animal Care and Use Committee of the Johns Hopkins University School of Medicine. Client-owned dogs with confirmed metastatic OS were recruited from owners with written informed consent.
: The authors declare no competing interests.
